APO Research
Talk to an analyst

APO RESEARCH · REPORT

Children Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Children Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchChildren Influenza Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Children Influenza Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Children Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Children Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Children Influenza Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Children Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Children Influenza Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Children Influenza Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Children Influenza Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Children Influenza Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Children Influenza Vaccine Segment by Company

BCHT

CCBIO

CSL

Hulan Bio

KM Biologics

Sanofi Pasteur

Sinovac

Viatris

AstraZeneca

GSK

Jiangsu GDK

Children Influenza Vaccine Segment by Type

Nasal Spray

Injection

Children Influenza Vaccine Segment by Application

Public

Private

Children Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Children Influenza Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Children Influenza Vaccine Industry Trends Table 2. Children Influenza Vaccine Industry Drivers Table 3. Children Influenza Vaccine Industry Opportunities and Challenges Table 4. Children Influenza Vaccine Industry Restraints Table 5. Global Children Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Children Influenza Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Children Influenza Vaccine Sales Market Share by Manufacturers Table 9. Global Children Influenza Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Children Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Children Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Children Influenza Vaccine Manufacturers, Product Type & Application Table 13. Global Children Influenza Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Children Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nasal Spray Table 17. Major Manufacturers of Injection Table 18. Global Children Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Children Influenza Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Children Influenza Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Children Influenza Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Children Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Children Influenza Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Children Influenza Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Children Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Children Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Public Table 29. Major Manufacturers of Private Table 30. Global Children Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Children Influenza Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Children Influenza Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Children Influenza Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Children Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Children Influenza Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Children Influenza Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Children Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Children Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Children Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Children Influenza Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Children Influenza Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Children Influenza Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Children Influenza Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Children Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Children Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Children Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Children Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Children Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 62. BCHT Company Information Table 63. BCHT Business Overview Table 64. BCHT Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. BCHT Children Influenza Vaccine Product Portfolio Table 66. BCHT Recent Development Table 67. CCBIO Company Information Table 68. CCBIO Business Overview Table 69. CCBIO Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CCBIO Children Influenza Vaccine Product Portfolio Table 71. CCBIO Recent Development Table 72. CSL Company Information Table 73. CSL Business Overview Table 74. CSL Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. CSL Children Influenza Vaccine Product Portfolio Table 76. CSL Recent Development Table 77. Hulan Bio Company Information Table 78. Hulan Bio Business Overview Table 79. Hulan Bio Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hulan Bio Children Influenza Vaccine Product Portfolio Table 81. Hulan Bio Recent Development Table 82. KM Biologics Company Information Table 83. KM Biologics Business Overview Table 84. KM Biologics Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. KM Biologics Children Influenza Vaccine Product Portfolio Table 86. KM Biologics Recent Development Table 87. Sanofi Pasteur Company Information Table 88. Sanofi Pasteur Business Overview Table 89. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur Children Influenza Vaccine Product Portfolio Table 91. Sanofi Pasteur Recent Development Table 92. Sinovac Company Information Table 93. Sinovac Business Overview Table 94. Sinovac Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sinovac Children Influenza Vaccine Product Portfolio Table 96. Sinovac Recent Development Table 97. Viatris Company Information Table 98. Viatris Business Overview Table 99. Viatris Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Viatris Children Influenza Vaccine Product Portfolio Table 101. Viatris Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. AstraZeneca Children Influenza Vaccine Product Portfolio Table 106. AstraZeneca Recent Development Table 107. GSK Company Information Table 108. GSK Business Overview Table 109. GSK Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. GSK Children Influenza Vaccine Product Portfolio Table 111. GSK Recent Development Table 112. Jiangsu GDK Company Information Table 113. Jiangsu GDK Business Overview Table 114. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Jiangsu GDK Children Influenza Vaccine Product Portfolio Table 116. Jiangsu GDK Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Children Influenza Vaccine Distributors List Table 120. Children Influenza Vaccine Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Children Influenza Vaccine Product Image Figure 2. Global Children Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Children Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Children Influenza Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Children Influenza Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nasal Spray Image Figure 9. Injection Image Figure 10. Global Children Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Children Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Children Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Children Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Children Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Children Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Public Image Figure 17. Private Image Figure 18. Global Children Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Children Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Children Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Children Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Children Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Children Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Children Influenza Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Children Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Children Influenza Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Children Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Children Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Children Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Children Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Children Influenza Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Children Influenza Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Injection
Applications
  • Public
  • Private
Companies covered
  • BCHT
  • CCBIO
  • CSL
  • Hulan Bio
  • KM Biologics
  • Sanofi Pasteur
  • Sinovac
  • Viatris
  • AstraZeneca
  • GSK
  • Jiangsu GDK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Children Influenza Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Children Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Children Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Children Influenza Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Children Influenza Vaccine Market Dynamics
  1. 2.1 Children Influenza Vaccine Industry Trends
  2. 2.2 Children Influenza Vaccine Industry Drivers
  3. 2.3 Children Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Children Influenza Vaccine Industry Restraints
3 Children Influenza Vaccine Market by Manufacturers
  1. 3.1 Global Children Influenza Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Children Influenza Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Children Influenza Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Children Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Children Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Children Influenza Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Children Influenza Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Children Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Children Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Children Influenza Vaccine Market by Type
  1. 4.1 Children Influenza Vaccine Type Introduction
  2. 4.1.1 Nasal Spray
  3. 4.1.2 Injection
  4. 4.2 Global Children Influenza Vaccine Sales by Type
  5. 4.2.1 Global Children Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Children Influenza Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Children Influenza Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Children Influenza Vaccine Revenue by Type
  9. 4.3.1 Global Children Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Children Influenza Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Children Influenza Vaccine Revenue Market Share by Type (2021-2032)
5 Children Influenza Vaccine Market by Application
  1. 5.1 Children Influenza Vaccine Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Children Influenza Vaccine Sales by Application
  5. 5.2.1 Global Children Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Children Influenza Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Children Influenza Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Children Influenza Vaccine Revenue by Application
  9. 5.3.1 Global Children Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Children Influenza Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Children Influenza Vaccine Revenue Market Share by Application (2021-2032)
6 Global Children Influenza Vaccine Sales by Region
  1. 6.1 Global Children Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Children Influenza Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Children Influenza Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Children Influenza Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Children Influenza Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Children Influenza Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Children Influenza Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Children Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Children Influenza Vaccine Revenue by Region
  1. 7.1 Global Children Influenza Vaccine Revenue by Region
  2. 7.1.1 Global Children Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Children Influenza Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Children Influenza Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Children Influenza Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Children Influenza Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Children Influenza Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Children Influenza Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Children Influenza Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Children Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BCHT
  2. 8.1.1 BCHT Company Information
  3. 8.1.2 BCHT Business Overview
  4. 8.1.3 BCHT Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BCHT Children Influenza Vaccine Product Portfolio
  6. 8.1.5 BCHT Recent Developments
  7. 8.2 CCBIO
  8. 8.2.1 CCBIO Company Information
  9. 8.2.2 CCBIO Business Overview
  10. 8.2.3 CCBIO Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CCBIO Children Influenza Vaccine Product Portfolio
  12. 8.2.5 CCBIO Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Children Influenza Vaccine Product Portfolio
  18. 8.3.5 CSL Recent Developments
  19. 8.4 Hulan Bio
  20. 8.4.1 Hulan Bio Company Information
  21. 8.4.2 Hulan Bio Business Overview
  22. 8.4.3 Hulan Bio Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
  24. 8.4.5 Hulan Bio Recent Developments
  25. 8.5 KM Biologics
  26. 8.5.1 KM Biologics Company Information
  27. 8.5.2 KM Biologics Business Overview
  28. 8.5.3 KM Biologics Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
  30. 8.5.5 KM Biologics Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 Sinovac
  38. 8.7.1 Sinovac Company Information
  39. 8.7.2 Sinovac Business Overview
  40. 8.7.3 Sinovac Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sinovac Children Influenza Vaccine Product Portfolio
  42. 8.7.5 Sinovac Recent Developments
  43. 8.8 Viatris
  44. 8.8.1 Viatris Company Information
  45. 8.8.2 Viatris Business Overview
  46. 8.8.3 Viatris Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Viatris Children Influenza Vaccine Product Portfolio
  48. 8.8.5 Viatris Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 GSK
  56. 8.10.1 GSK Company Information
  57. 8.10.2 GSK Business Overview
  58. 8.10.3 GSK Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GSK Children Influenza Vaccine Product Portfolio
  60. 8.10.5 GSK Recent Developments
  61. 8.11 Jiangsu GDK
  62. 8.11.1 Jiangsu GDK Company Information
  63. 8.11.2 Jiangsu GDK Business Overview
  64. 8.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
  66. 8.11.5 Jiangsu GDK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Children Influenza Vaccine Value Chain Analysis
  2. 9.1.1 Children Influenza Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Children Influenza Vaccine Production Mode & Process
  6. 9.2 Children Influenza Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Children Influenza Vaccine Distributors
  9. 9.2.3 Children Influenza Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst